The association of anti-tumor necrosis factor and thiopurine therapy with the risk of lymphoma among Inflammatory Bowel Disease patients: A nation-wide study from the epi-IIRN

被引:0
|
作者
Waterman, M. [1 ]
Lavi, I. [2 ]
Harel, S. [3 ]
Focht, G. [3 ]
Weisband, J. Loewenberg [4 ]
Greenfeld, S. [5 ]
Kariv, R. [5 ]
Ledderman, N. [6 ]
Matz, E. [7 ]
Keinan-Boker, L. [8 ]
Eizenstein, S. [9 ]
Dotan, I. [10 ]
Turner, D. [3 ]
Levi, Z. [10 ]
机构
[1] Technion Israel Inst Technol, Dept Gastroenterol, Rambam Hlth Care Campus, Rappaport Fac Med, Haifa, Israel
[2] Lady Davis Carmel Med Ctr, Dept Community Med & Epidemiol, Haifa, Israel
[3] Hebrew Univ Jerusalem, Juliet Keidan Inst Pediat Gastroenterol Hepatol &, Shaare Zedek Med Ctr, Jerusalem, Israel
[4] Clalit Hlth Serv, Clalit Res Inst, Chief Phys Off, Tel Aviv, Israel
[5] Tel Aviv Univ, Maccabi Hlth Serv, Sackler Fac Med, Tel Aviv, Israel
[6] Meuhedet, Hlth Serv, Tel Aviv, Israel
[7] Leumit, Hlth Serv, Tel Aviv, Israel
[8] Univ Haifa, Sch Publ Hlth, Haifa, Israel
[9] Tel Aviv Univ, Sch Publ Hlth, Sackler Fac Med, Tel Aviv, Israel
[10] Tel Aviv Univ, Div Gastroenterol, Rabin Med Ctr Petah Tikva, Sackler Fac Med, Tel Aviv, Israel
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
DOP72
引用
收藏
页码:I115 / I1116
页数:2
相关论文
共 50 条
  • [31] Aortic Stiffness in Patients With Inflammatory Bowel Disease Reduced After Anti-Tumor Necrosis Factor Therapy
    Zanoli, Luca
    Inserra, Gaetano
    Cappello, Maria
    Ozturk, Kadir
    Castellino, Pietro
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (08) : 981 - 982
  • [32] Risk factors for tuberculosis in inflammatory bowel disease: anti-tumor necrosis factor and hospitalization
    Riestra, Sabin
    de Francisco, Ruth
    Arias-Guillen, Miguel
    Saro, Cristina
    Garcia-Alvarado, Maria
    Duque, Jose M.
    Jose Palacios, Juan
    Munoz, Fernando
    Blanco, Lorena
    Castano, Olegario
    Perez-Martinez, Isabel
    Martinez-Camblor, Pablo
    Perez-Hernandez, Dolores
    Suarez, Adolfo
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2016, 108 (09) : 541 - 549
  • [33] Characteristics of Skin Lesions Associated With Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease A Cohort Study
    Cleynen, Isabelle
    Van Moerkercke, Wouter
    Billiet, Thomas
    Vandecandelaere, Pieter
    Vande Casteele, Niels
    Breynaert, Christine
    Ballet, Vera
    Ferrante, Marc
    Noman, Maja
    Van Assche, Gert
    Rutgeerts, Paul
    van den Oord, Joost J.
    Gils, Ann
    Segaert, Siegfried
    Vermeire, Severine
    [J]. ANNALS OF INTERNAL MEDICINE, 2016, 164 (01) : 10 - +
  • [34] Anti-Tumor Necrosis Factor Treatment of Inflammatory Bowel Disease in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
    Jegadeesan, Ramprasad
    Kochhar, Gursimran
    Hayat, Umar
    Kim, Ahyoung J.
    Lan, Nan
    Sanaka, Madhusudhan R.
    Shen, Bo
    Romero-Marrero, Carlos
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S396 - S397
  • [35] Risks of Serious Infection or Lymphoma With Anti-Tumor Necrosis Factor Therapy for Pediatric Inflammatory Bowel Disease: A Systematic Review
    Dulai, Parambir S.
    Thompson, Kimberly D.
    Blunt, Heather B.
    Dubinsky, Marla C.
    Siegel, Corey A.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (09) : 1443 - 1451
  • [36] Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease?
    Park, Jihye
    Cheon, Jae Hee
    [J]. GUT AND LIVER, 2021, 15 (05) : 641 - 642
  • [37] Indicators of suboptimal response to anti-tumor necrosis factor therapy in patients from China with inflammatory bowel disease: results from the EXPLORE study
    Ji Li
    Zhanju Liu
    Pinjin Hu
    Zhonghui Wen
    Qian Cao
    Xiaoping Zou
    Yan Chen
    Yingde Wang
    Jie Zhong
    Xizhong Shen
    Dirk Demuth
    Olga Fadeeva
    Li Xie
    Jun Chen
    Jiaming Qian
    [J]. BMC Gastroenterology, 22
  • [38] Indicators of suboptimal response to anti-tumor necrosis factor therapy in patients from China with inflammatory bowel disease: results from the EXPLORE study
    Li, Ji
    Liu, Zhanju
    Hu, Pinjin
    Wen, Zhonghui
    Cao, Qian
    Zou, Xiaoping
    Chen, Yan
    Wang, Yingde
    Zhong, Jie
    Shen, Xizhong
    Demuth, Dirk
    Fadeeva, Olga
    Xie, Li
    Chen, Jun
    Qian, Jiaming
    [J]. BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [39] Rates and Predictors of Vaccinations Among Inflammatory Bowel Disease Patients Receiving Anti-Tumor Necrosis Factor Agents
    Hung-Viet Pham
    Hasan, Imran
    Udaltsova, Natalia
    Pham, Kathy
    Abramson, Oren
    Armstrong, Mary Anne
    Postlethwaite, Debbie
    Li, Dan
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (01) : 209 - 217
  • [40] Predictors of Response to First and Second Anti-Tumor Necrosis Factor Agents Among Patients With Inflammatory Bowel Disease
    Patel, Ronak V.
    Barnes, Edward L.
    Collins, Emily
    Cao, Bonnie
    Carrellas, Madeline
    Crowell, Anne Marie
    States, Justine
    Hurwitz, Shelley
    Korzenik, Joshua R.
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S413 - S414